Authors:
Address: Department of Infectious Diseases, Austin Health, Heidelberg, Vic., Australia.
Journal:
Publication:
abstractWe assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus Doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
Related ArticlesReview How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.J Antimicrob Chemother. 2003
Review How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman IM. J Antimicrob Chemother. 2003 Oct; 52(4):555-63. Epub 2003 Sep 12.
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.Clin Infect Dis. 2008
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, et al. Clin Infect Dis. 2008 May 15; 46(10):1513-21.
Review Elderly patients with community-acquired pneumonia: optimal treatment strategies.Drugs Aging. 2011
Review Elderly patients with community-acquired pneumonia: optimal treatment strategies.
Thiem U, Heppner HJ, Pientka L. Drugs Aging. 2011 Jul 1; 28(7):519-37.
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.Eur J Clin Microbiol Infect Di...
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
García Vázquez E, Mensa J, Martínez JA, Marcos MA, Puig J, Ortega M, Torres A. Eur J Clin Microbiol Infect Dis. 2005 Mar; 24(3):190-5.
Review The atypical pneumonias: clinical diagnosis and importance.Clin Microbiol Infect. 2006
Review The atypical pneumonias: clinical diagnosis and importance.
Cunha BA. Clin Microbiol Infect. 2006 May; 12 Suppl 3:12-24.
To
top
•
Home
Show
map | Diseases | Vaccination
| Chronic disease | Medicine
| Pregnancy
| Heat & Sunburn | Cold | Security
| Useful tips | Faq
| News
TraveldoctorOnline 2001 •
Disclaimer • webmaster
